DGAP-News
Balda records positive revenue and operating result trend in the first half-year
DGAP-News: Balda AG / Key word(s): Half Year Results
Balda records positive revenue and operating result trend in the first
half-year
11.02.2015 / 07:30
---------------------------------------------------------------------
- Revenue up by EUR 5.5 million to EUR 40.4 million
- EBITDA (EUR 2.7 million) and EBIT (EUR 0.4 million) continue positive
trend as expected
- CEO Oliver Oechsle: "significant step closer to operational turnaround"
- Revenue forecast for 2014 / 2015 financial year again confirmed:
revenue at the top end of the EUR 73 to 78 million range with positive
EBIT
Bad Oeynhausen, 11 February 2015 - Balda AG posted consolidated revenue of
EUR 40.4 million in the first half-year 2014 / 2015 compared to EUR 34.9
million in the equivalent period of the previous year. Higher sales in
healthcare products in the Europe segment primarily contributed to this
rise.
"The significant increase in demand for healthcare products indicates that
our more intensive activities are paying off. We are closer to the market
and our customers appreciate our product quality and dependability,"
remarked Oliver Oechsle, CEO of Balda AG, adding: "This confirms that we
have adopted the right approach and that Balda is back on track."
Key revenue and earnings figures for the Balda Group in the first half-year
2014/2015
After generating total revenue of EUR 20.7 million in the first quarter,
the positive trend continued in the second with the figure coming in at
EUR 19.7 million. This means the Balda Group achieved total revenue of EUR
40.4 million in the period under review compared with EUR 34.9 million in
the equivalent period of the previous year. This represents a 15.8 %
increase. As in the first three months, Balda reported significantly
stronger demand for med-tech products.
In the period from July to December 2014, Balda AG posted earnings before
interest, tax, depreciation and amortization (EBITDA) of EUR 2.7 million
compared to EUR 1.1 million in the prior-year period, which represents an
EBITDA margin of 6.8 %. At operational level, the Group reported earnings
before interest and taxes (EBIT) of EUR 0.4 million after EBIT came in at a
loss of EUR -1.5 million in the equivalent period of the previous year. The
EBIT margin in the first half-year of the financial year 2014 / 2015
therefore stood at 1.0 %.
At EUR 3.7 million, the company's consolidated earnings after taxes were
significantly below the previous year's figure of EUR 11.1 million, which
is attributable to a lower financial result due to weaker currency results.
"After the first half-year 2014/2015, our figures prove that we have taken
- Revenue up by EUR 5.5 million to EUR 40.4 million
- EBITDA (EUR 2.7 million) and EBIT (EUR 0.4 million) continue positive
trend as expected
- CEO Oliver Oechsle: "significant step closer to operational turnaround"
- Revenue forecast for 2014 / 2015 financial year again confirmed:
revenue at the top end of the EUR 73 to 78 million range with positive
EBIT
Bad Oeynhausen, 11 February 2015 - Balda AG posted consolidated revenue of
EUR 40.4 million in the first half-year 2014 / 2015 compared to EUR 34.9
million in the equivalent period of the previous year. Higher sales in
healthcare products in the Europe segment primarily contributed to this
rise.
"The significant increase in demand for healthcare products indicates that
our more intensive activities are paying off. We are closer to the market
and our customers appreciate our product quality and dependability,"
remarked Oliver Oechsle, CEO of Balda AG, adding: "This confirms that we
have adopted the right approach and that Balda is back on track."
Key revenue and earnings figures for the Balda Group in the first half-year
2014/2015
After generating total revenue of EUR 20.7 million in the first quarter,
the positive trend continued in the second with the figure coming in at
EUR 19.7 million. This means the Balda Group achieved total revenue of EUR
40.4 million in the period under review compared with EUR 34.9 million in
the equivalent period of the previous year. This represents a 15.8 %
increase. As in the first three months, Balda reported significantly
stronger demand for med-tech products.
In the period from July to December 2014, Balda AG posted earnings before
interest, tax, depreciation and amortization (EBITDA) of EUR 2.7 million
compared to EUR 1.1 million in the prior-year period, which represents an
EBITDA margin of 6.8 %. At operational level, the Group reported earnings
before interest and taxes (EBIT) of EUR 0.4 million after EBIT came in at a
loss of EUR -1.5 million in the equivalent period of the previous year. The
EBIT margin in the first half-year of the financial year 2014 / 2015
therefore stood at 1.0 %.
At EUR 3.7 million, the company's consolidated earnings after taxes were
significantly below the previous year's figure of EUR 11.1 million, which
is attributable to a lower financial result due to weaker currency results.
"After the first half-year 2014/2015, our figures prove that we have taken
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte